Role of arachidonic acid lipoxygenase metabolites in acetylcholine-induced relaxations of mouse arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 3, 2011, Pages

  Gauthier, Kathryn M ^a   Goldman, Daniel H ^a   Aggarwal, Nitin T ^a   Chawengsub, Yuttana ^a   Falck, J R ^b   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

12 15 lipoxygenase; Endothelium; Endothelium derived hypolarizing factor; Mass spectrometry; Potassium channels; Trihydroxyeicosatrienoic acids

Indexed keywords

14,15 EPOXYEICOSA 5 ENOIC ACID; 3 AMINO 1 (3 TRIFLUOROMETHYLPHENYL) 2 PYRAZOLINE; ACETYLCHOLINE; APAMIN; ARACHIDONATE LIPOXYGENASE; EPOXYICOSATRIENOIC ACID; HYDROXYEPOXYEICOSATRIENOIC ACID; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; INDOMETACIN; MESSENGER RNA; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; NORDIHYDROGUAIARETIC ACID; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; TRIHYDROXYICOSATRIENOIC ACID; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ARTERY BLOOD FLOW; ARTERY ENDOTHELIUM; ARTERY RESISTANCE; ARTICLE; CAROTID ARTERY; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIASTEREOISOMER; FATTY ACID METABOLISM; FEMALE; FEMORAL ARTERY; IMMUNOBLOTTING; ISOMETRICS; MALE; MAMMARY ARTERY; MASS SPECTROMETRY; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SMOOTH MUSCLE RELAXATION; THORACIC AORTA; WESTERN BLOTTING;

8,11,14-EICOSATRIENOIC ACID; ACETYLCHOLINE; AMIDES; ANIMALS; APAMIN; ARACHIDONATE LIPOXYGENASES; ARTERIES; FEMALE; INDOMETHACIN; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; NITROARGININE; NORDIHYDROGUAIARETIC ACID; VASODILATION; VASODILATOR AGENTS;

EID: 79955065800     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00696.2009     Document Type: Article

References (58)

1. Agarwal R, Wang ZY, Bik DP, Mukhtar H. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. Drug Metab Dispos 19: 620-624, 1991.
2. Aggarwal NT, Chawengsub Y, Gauthier KM, Viita H, Yla-Herttuala S, Campbell WB. Endothelial 15-lipoxygenase-1 overexpression increases acetylcholine-induced hypotension and vasorelaxation in rabbits. Hypertension 51: 246-251, 2008.
3. Argentieri DC, Ritchie DM, Ferro MP, Kirchner T, Wachter MP, Anderson DW, Rosenthale ME, Capetola RJ. Tepoxalin: a dual cyclooxygenase/ 5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile. J Pharmacol Exp Ther 271: 1399-1408, 1994.
4. Campbell WB, Falck JR. Arachidonic acid metabolites as endotheliumderived hyperpolarizing factors. Hypertension 49: 590-596, 2007.
5. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
6. Campbell WB, Spitzbarth N, Gauthier KM, Pfister SL. 11,12,15-Trihydroxyeicosatrienoic acid mediates acetylcholine-induced relaxations in the rabbit aorta. Am J Physiol Heart Circ Physiol 285: H2648-H2656, 2003.
7. Chataigneau T, Feletou M, Huang PL, Fishman MC, Duhault J, Vanhoutte PM. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol 126: 219-226, 1999.
8. Chawengsub Y, Aggarwal NT, Nithipatikom K, Gauthier KM, Anjaiah S, Hammock BD, Falck JR, Campbell WB. Identification of 15-hydroxy-11,12-epoxyeicosatrienoic acid as a vasoactive 15-lipoxygenase metabolite in rabbit aorta. Am J Physiol Heart Circ Physiol 294: H1348-H1356, 2008.
9. Chawengsub Y, Gauthier KM, Campbell WB. Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone. Am J Physiol Heart Circ Physiol 297: H495-H507, 2009.
10. Chen XS, Kurre U, Jenkins NA, Copeland NG, Funk CD. cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases. J Biol Chem 269: 13979-13987, 1994.
11. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation 92: 3337-3349, 1995.
12. Cui L, Isbell M, Chawengsub Y, Falck JR, Campbell WB, Nithipatikom K. Structural characterization of monohydroxyeicosatetraenoic acids and dihydroxy-and trihydroxyeicosatrienoic acids by ESI-FTICR. J Am Soc Mass Spectrom 19: 569-585, 2008.
13. De Mey JG, Claeys M, Vanhoutte PM. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. J Pharmacol Exp Ther 222: 166-173, 1982.
14. Ding H, Hashem M, Wiehler WB, Lau W, Martin J, Reid J, Triggle C. Endothelial dysfunction in the streptozotocin-induced diabetic apoEdeficient mouse. Br J Pharmacol 146: 1110-1118, 2005.
15. Dora KA, Sandow SL, Gallagher NT, Takano H, Rummery NM, Hill CE, Garland CJ. Myoendothelial gap junctions may provide the pathway for EDHF in mouse mesenteric artery. J Vasc Res 40: 480-490, 2003.
16. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272, 1998.
17. Ellis A, Cheng ZJ, Li Y, Jiang YF, Yang J, Pannirselvam M, Ding H, Hollenberg MD, Triggle CR. Effects of a Western diet versus high glucose on endothelium-dependent relaxation in murine micro-and macro-vasculature. Eur J Pharmacol 601: 111-117, 2008.
18. Endsley MP, Aggarwal N, Isbell MA, Wheelock CE, Hammock BD, Falck JR, Campbell WB, Nithipatikom K. Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: location, hydrolysis and 12-lipoxygenase metabolism. Int J Cancer 121: 984-991, 2007.
19. Falck JR, Barma DK, Mohapatra B, Bandyopadhyay A, Reddy KM, Qi J, Campbell WB. Asymmetric synthesis of the stereoisomers of 11,12,15(S)-trihydroxy-5(Z),8(Z),13(Z)-trienoic acid, a potent endothelium-derived vasodilator. Bioorganic Med Chem Lett 14: 4987-4990, 2004.
20. Falck JR, Manna S, Viala J, Siddhanta AK. Arachidonate epoxygenase: inhibitors and metabolite analogs. Tetrahedron Lett 26: 2287-2290.
21. + channels. Am J Physiol Regul Integr Comp Physiol 281: R246-R253, 2001.
22. Félétou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Where are we now? Arterioscler Thromb Vasc Biol 23: 729-736, 2004.
23. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-497, 1999.
24. Furchgott RF, Zawadzki JW. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
25. Gauthier KM, Chawengsub Y, Goldman DH, Conrow RE, Anjaiah S, Falck JR, Campbell WB. 11(R),12(S),15(S)-trihydroxyeicosa-5(Z),8(Z),13(E)-trienoic acid: an endothelium-derived 15-lipoxygenase metabolite that relaxes rabbit aorta. Am J Physiol Heart Circ Physiol 294: H1467-H1472, 2008.
26. + currents mediate arachidonic acid-induced relaxations of rabbit aorta. Hypertension 43: 413-419, 2004.
27. Hercule HC, Schunck WH, Gross V, Seringer J, Leung FP, Weldon SM, da Costa Goncalves AC, Huang Y, Luft FC, Gollasch M. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice. Arterioscler Thromb Vasc Biol 29: 54-60, 2009.
28. Hidaka T, Takeo K, Hosoe K, Katasumi I, Yamashita T, Watanabe K. Inhibition of polymorphonuclear leukocyte 5-lipoxygenase and platelet cyclooxygenase by α-(3,5-di-tert-butyl-4-hydroxybenzylidene)γ-butyrolactone (KME-4), a new anti-inflammatory drug. Jpn J Pharmacol 38: 267-272, 1985.
29. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
30. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, Maylie J. A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA 94: 11651-11656, 1997.
31. Jackson WF. Potassium channels in the peripheral microcirculation. Microcirculation 1: 113-127, 2005.
32. Kaiser L, Hull SS Jr, Sparks HV Jr. Methylene blue and ETYA block flow-dependent dilation in canine femoral artery. Am J Physiol Heart Circ Physiol 250: H974-H981, 1986.
33. Kanamaru K, Waga S, Kojima T, Fujimoto K, Itoh H. Endotheliumdependent relaxation of canine basilar arteries. Part 1: difference between acetylcholine-and A23187-induced relaxation and involvement of lipoxygenase metabolite(s). Stroke 18: 932-937, 1987.
34. Kuhn H, Thiele BJ, Ostareck-Lederer A, Stender H, Suzuki H, Yoshimoto T, Yamamoto S. Bacterial expression, purification and partial characterization of recombinant rabbit reticulocyte 15-lipoxygenase. Biochim Biophys Acta 1168: 73-78, 1993.
35. Larsen BT, Gutterman DD, Sato A, Toyama K, Campbell WB, Zeldin DC, Manthati VL, Falck JR, Miura H. Hydrogen peroxide inhibits cytochrome P450 epoxygenases: interaction between two endotheliumderived hyperpolarizing factors. Circ Res 102: 59-67, 2008.
36. Larsen BT, Miura H, Hatoum OA, Campbell WB, Hammock BD, Zeldin DC, Falck JR, Gutterman DD. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BKCa channels: implications for soluble epoxide hydrolase inhibition. Am J Physiol Heart Circ Physiol 290: H491-H499, 2006.
37. Ledoux J, Werner ME, Brayden JE, Nelson MT. Calcium-activated potassium channels and the regulation of vascular tone. Physiology 21: 69-78, 2006.
38. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 209: 909-913, 2002.
39. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A. Hydrogen peroxide is an endothe-lium-derived hyperpolarizing factor in mice. J Clin Invest 106: 1521-1530, 2000.
40. Miller AW, Katakam PV, Lee HC, Tulbert CD, Busija DW, Weintraub NL. Arachidonic acid-induced vasodilation of rat small mesenteric arteries is lipoxygenase-dependent. J Pharmacol Exp Ther 304: 139-44, 2003.
41. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 30: 293-331, 1978.
42. Murphy RC, Barkley RM, Berry KZ, Hankin J, Harrison K, Johnston C, Krank J, McAnoy A, Uhlson C, Zarini S. Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal Biochem 346: 1-42, 2005.
43. Ong CE, Coulter S, Birkett DJ, Bhasker CR, Miners JO. The xenobiotic inhibitor profile of cytochrome P4502C8. Br J Clin Pharmacol 50: 573-580, 2000.
44. Pannirselvam M, Ding H, Anderson TJ, Triggle CR. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur J Pharmacol 551: 98-107, 2006.
45. Pfister SL, Campbell WB. Arachidonic acid-and acetylcholine-induced relaxations of rabbit aorta. Hypertension 20: 682-689, 1992.
46. Pfister SL, Spitzbarth N, Edgemond W, Campbell WB. Vasorelaxation by an endothelium-derived metabolite of arachidonic acid. Am J Physiol Heart Circ Physiol 270: H1021-H1030, 1996.
47. Pfister SL, Spitzbarth N, Nithipatikom K, Edgemond WS, Falck JR, Campbell WB. Identification of 11,14,15-and 11,12,15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta. J Biol Chem 273: 30879-30887, 1998.
48. Pfister SL, Spitzbarth N, Zeldin DC, Lafite P, Mansuy D, Campbell WB. Rabbit aorta converts 15-HPETE to trihydroxyeicosatrienoic acids; potential role of cytochrome P450 as endothelium-derived relaxing factors of rabbit aorta. Arch Biochem Biophys 420: 142-152, 2003.
49. Rittenhouse AR, Parker C, Brugnara C, Morgan KG, Alper SL. Inhibition of maxi-K currents in ferret portal vein smooth muscle cells by the antifungal clotrimazole. Am J Physiol Cell Physiol 273: C45-C56, 1997.
50. Shimokawa H, Matoba T. Does EDHF contribute to the control of peripheral resistance? Dialog Cardiovasc Med 6: 235-239, 2001.
51. Stapleton PA, Goodwill AG, James ME, Frisbee JC. Altered mechanisms of endothelium-dependent dilation in skeletal muscle arterioles with genetic hypercholesterolemia. Am J Physiol Regul Integr Comp Physiol 293: R1110-R1119, 2007.
52. Takaki A, Morikawa K, Tsutsui M, Murayama Y, Tekes E, Yamagishi H, Ohashi J, Yada T, Yanagihara N, Shimokawa H. Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. J Exp Med 205: 2053-2063, 2008.
53. Tang X, Holmes BB, Nithipatikom K, Hillard CJ, Kuhn H, Campbell WB. Reticulocyte 15-lipoxygenase-I is important in acetylcholine-induced endothelium-dependent vasorelaxation in rabbit aorta. Arterioscler Thromb Vasc Biol 26: 78-84, 2006.
54. Toda N. Mechanism of histamine actions in human coronary arteries. Circ Res 61: 280-286, 1987.
55. Weiss RH, Arnold JL, Estabrook RW. Transformation of an arachidonic acid hydroperoxide into epoxyhydroxy and trihydroxy fatty acids by liver microsomal cytochrome P-450. Arch Biochem Biophys 252: 334-338, 1987.
56. Yi XY, Gauthier KM, Cui L, Nithipatikom K, Falck JR, Campbell WB. Metabolism of adrenic acid to vasodilatory 1α,1β-dihomo-epoxyeicosatrienoic acids by bovine coronary arteries. Am J Physiol Heart Circ Physiol 292: H2265-H2274, 2007.
57. +. Am J Physiol Heart Circ Physiol 293: H152-H159, 2007.
58. Zhou W, Wang XL, Kaduce TL, Spector AA, Lee HC. Impaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 288: H2210-H2218, 2005.